Review article · 2019 · Open access
Key enablers and barriers to implementing adaptive pathways in the European setting
British Journal of Clinical Pharmacology, 85(7), 1427–1433 · Published 8 March 2019 · DOI 10.1111/bcp.13916
In brief
“Key enablers and barriers to implementing adaptive pathways in the European setting” is a 2019 review article by Juan Carlos Rejón-Parrilla and 2 co-authors, published in British Journal of Clinical Pharmacology. OpenAlex counts 0 citations as of 19 November 2026. It is open access: the full text is free to read at PubMed Central.
- Citations
- 0
- References
- 18
- Authors
- 3
Abstract
In 2016, the European Medicines Agency published the conclusions of its pilot on adaptive pathways, with products in early stages of development still building up to their marketing authorisation. Adaptive pathways rests on three principles: iterative development; gathering evidence through real-life use to supplement clinical trial data; and early engagement of patients, payers and health technology assessment bodies in discussions on a medicine's development. While the pilot has now finished, the practical system-wide implications of employing the adaptive pathways approach are not known and further consideration of these three principles is required. In this paper we used the three principles that underpin adaptive pathways to discuss main scientific and European policy developments likely to determine progress on further implementing adaptive pathways in the European setting.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Rejón-Parrilla, J. C., Jonsson, P. F., & Bouvy, J. C. (2019). Key enablers and barriers to implementing adaptive pathways in the European setting. British Journal of Clinical Pharmacology, 85(7), 1427–1433. https://doi.org/10.1111/bcp.13916
MLA 9
Rejón-Parrilla, Juan Carlos, et al. “Key enablers and barriers to implementing adaptive pathways in the European setting.” British Journal of Clinical Pharmacology, vol. 85, no. 7, 2019, pp. 1427–1433. https://doi.org/10.1111/bcp.13916.
Chicago
Rejón-Parrilla, Juan Carlos, Pall F. Jonsson, and Jacoline C. Bouvy. 2019. “Key enablers and barriers to implementing adaptive pathways in the European setting.” British Journal of Clinical Pharmacology 85 (7): 1427–1433. https://doi.org/10.1111/bcp.13916.
Harvard
Rejón-Parrilla, J. C., Jonsson, P. F. and Bouvy, J. C. (2019) ‘Key enablers and barriers to implementing adaptive pathways in the European setting’, British Journal of Clinical Pharmacology, 85(7), pp. 1427–1433. doi:10.1111/bcp.13916.
IEEE
J. C. Rejón-Parrilla, P. F. Jonsson, and J. C. Bouvy, “Key enablers and barriers to implementing adaptive pathways in the European setting,” British Journal of Clinical Pharmacology, vol. 85, no. 7, pp. 1427–1433, 2019, doi: 10.1111/bcp.13916.
BibTeX
@article{rejonparrilla2019enablers,
title = {{Key enablers and barriers to implementing adaptive pathways in the European setting}},
author = {Rejón-Parrilla, Juan Carlos and Jonsson, Pall F. and Bouvy, Jacoline C.},
journal = {British Journal of Clinical Pharmacology},
year = {2019},
volume = {85},
number = {7},
pages = {1427--1433},
doi = {10.1111/bcp.13916},
url = {https://doi.org/10.1111/bcp.13916}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- adaptive pathways
- regulatory implementation
- European Medicines Agency
- iterative development
- real-world evidence
- health technology assessment
- drug development
- regulatory policy
Work with this paper
Most-cited papers in Economics, Econometrics and Finance
- Theory of the firm: Managerial behavior, agency costs and ownership structureMichael C. Jensen, William H. Meckling · Journal of Financial Economics · 1976 · 77,585 citations
- Institutions, Institutional Change and Economic PerformanceDouglass C. North · Cambridge University Press eBooks · 1990 · 34,377 citations
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.John E. Ware, Cathy Donald Sherbourne · PubMed · 1992 · 33,943 citations
- Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment EquationsManuel Arellano, Stephen R. Bond · The Review of Economic Studies · 1991 · 33,778 citations
- Co-Integration and Error Correction: Representation, Estimation, and TestingRobert F. Engle, C.W.J. Granger · Econometrica · 1987 · 32,847 citations
Questions about this paper
How do I cite this paper in APA style?
Rejón-Parrilla, J. C., Jonsson, P. F., & Bouvy, J. C. (2019). Key enablers and barriers to implementing adaptive pathways in the European setting. British Journal of Clinical Pharmacology, 85(7), 1427–1433. https://doi.org/10.1111/bcp.13916
How many times has this paper been cited?
0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at PubMed Central: sign in and open the full text from this page.
Who wrote this paper?
Juan Carlos Rejón-Parrilla, Pall F. Jonsson, Jacoline C. Bouvy.
What is the DOI of this paper?
10.1111/bcp.13916, permanently at https://doi.org/10.1111/bcp.13916. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.